Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.23.16 (
HIV-1 protease
)
2,107
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In human immunodeficiency virus-1 (HIV-1), reverse transcriptase (RT) is encoded as a 66 kDa protein,
p66
, in the Gag-Pol polyprotein. This protein is proteolytically cleaved by
HIV-1 protease
(PR) to finally generate a mature RT that is a heterodimer, composed of a
p66
subunit and a
p66
-derived 51 kDa subunit, p51. In our prior work, we demonstrated that tRNA
Lys3
binding to
p66
/
p66
facilitates efficient cleavage of
p66
to p51 by PR. However, tRNA
Lys3
is known to be recruited to the virus by forming a complex with lysyl-tRNA synthetase (LysRS). Herein, we tested whether LysRS can have an effect on RT maturation
in vitro
. Importantly, our data show no significant differences in RT maturation in the presence of LysRS. Furthermore, no apparent
p66
/66 interaction with LysRS was observed. Although PR cleaved LysRS, it did not immediately release tRNA
Lys3
from LysRS. Thus, we conclude that a free fraction of tRNA
Lys3
, which is in equilibrium with a LysRS-bound form, interacts with
p66
/
p66
without any additional mechanism involving release of tRNA
Lys3
from LysRS. Given that only transient tRNA
Lys3
-
p66
/
p66
interaction is needed for efficient RT maturation, a small amount of free tRNA may be sufficient for this process. These studies reveal molecular level insights into RT maturation and will be useful for the design of cellular/viral experiments to better understand the role of tRNA in HIV-1 replication.
...
PMID:Effect of Lysyl-tRNA Synthetase on the Maturation of HIV-1 Reverse Transcriptase. 3268 28
<< Previous
1
2
3